 | • レポートコード：D0804-00704 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗ウイルス薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗ウイルス薬の種類別市場規模（ヌクレオチドポリメラーゼ阻害剤、逆転写酵素阻害剤、プロテアーゼ阻害剤）、用途別市場規模（HIV、肝炎、HSV、インフルエンザ）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：F. Hoffmann-La Roche、Cipla、AbbVie、GlaxoSmithKline、Aurobindo Pharma、Bristol-Myers-Squibb、Merck & Co、Johnson & Johnson、Dr Reddy’s ・地域別グローバル市場分析 2015年-2020年 ・抗ウイルス薬の北米市場（アメリカ、カナダ、メキシコ） ・抗ウイルス薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗ウイルス薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗ウイルス薬の南米市場（ブラジル、アルゼンチン） ・抗ウイルス薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヌクレオチドポリメラーゼ阻害剤、逆転写酵素阻害剤、プロテアーゼ阻害剤 ・用途別分析：HIV、肝炎、HSV、インフルエンザ ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Anti-Viral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anti-Viral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-Viral Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-Viral Drugs market has been segmented into
Nucleotide Polymerase Inhibitor
Reverse Transcriptase Inhibitor
Protease Inhibitor
By Application, Anti-Viral Drugs has been segmented into:
HIV
Hepatitis
HSV
Influenza
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-Viral Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-Viral Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-Viral Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anti-Viral Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-Viral Drugs Market Share Analysis
Anti-Viral Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-Viral Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-Viral Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anti-Viral Drugs are:
F. Hoffmann-La Roche
Cipla
AbbVie
GlaxoSmithKline
Aurobindo Pharma
Bristol-Myers-Squibb
Merck & Co
Johnson & Johnson
Dr Reddy’s
Among other players domestic and global, Anti-Viral Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Viral Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Viral Drugs, with price, sales, revenue and global market share of Anti-Viral Drugs in 2018 and 2019.
Chapter 3, the Anti-Viral Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Viral Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-Viral Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-Viral Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anti-Viral Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Viral Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Nucleotide Polymerase Inhibitor
1.2.3 Reverse Transcriptase Inhibitor
1.2.4 Protease Inhibitor
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Viral Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 HIV
1.3.3 Hepatitis
1.3.4 HSV
1.3.5 Influenza
1.4 Overview of Global Anti-Viral Drugs Market
1.4.1 Global Anti-Viral Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cipla
2.2.1 Cipla Details
2.2.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cipla SWOT Analysis
2.2.4 Cipla Product and Services
2.2.5 Cipla Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AbbVie SWOT Analysis
2.3.4 AbbVie Product and Services
2.3.5 AbbVie Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aurobindo Pharma
2.5.1 Aurobindo Pharma Details
2.5.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aurobindo Pharma SWOT Analysis
2.5.4 Aurobindo Pharma Product and Services
2.5.5 Aurobindo Pharma Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers-Squibb
2.6.1 Bristol-Myers-Squibb Details
2.6.2 Bristol-Myers-Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol-Myers-Squibb SWOT Analysis
2.6.4 Bristol-Myers-Squibb Product and Services
2.6.5 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co
2.7.1 Merck & Co Details
2.7.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co SWOT Analysis
2.7.4 Merck & Co Product and Services
2.7.5 Merck & Co Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Dr Reddy’s
2.9.1 Dr Reddy’s Details
2.9.2 Dr Reddy’s Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Dr Reddy’s SWOT Analysis
2.9.4 Dr Reddy’s Product and Services
2.9.5 Dr Reddy’s Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-Viral Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-Viral Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-Viral Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-Viral Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-Viral Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-Viral Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-Viral Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-Viral Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anti-Viral Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-Viral Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anti-Viral Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-Viral Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-Viral Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anti-Viral Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-Viral Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-Viral Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anti-Viral Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-Viral Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-Viral Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-Viral Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-Viral Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-Viral Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anti-Viral Drugs Sales and Growth Rate (2015-2020)
6.4 France Anti-Viral Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anti-Viral Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anti-Viral Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-Viral Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-Viral Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-Viral Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-Viral Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anti-Viral Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anti-Viral Drugs Sales and Growth Rate (2015-2020)
7.5 India Anti-Viral Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-Viral Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anti-Viral Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-Viral Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anti-Viral Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-Viral Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-Viral Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-Viral Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-Viral Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-Viral Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-Viral Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-Viral Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-Viral Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-Viral Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-Viral Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-Viral Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anti-Viral Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-Viral Drugs Price by Type (2015-2020)
11 Global Anti-Viral Drugs Market Segment by Application
11.1 Global Anti-Viral Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anti-Viral Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anti-Viral Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-Viral Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-Viral Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-Viral Drugs Market Forecast (2021-2025)
12.2.2 Europe Anti-Viral Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-Viral Drugs Market Forecast (2021-2025)
12.2.4 South America Anti-Viral Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-Viral Drugs Market Forecast (2021-2025)
12.3 Anti-Viral Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anti-Viral Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-Viral Drugs Market Share Forecast by Type (2021-2025)
12.4 Anti-Viral Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anti-Viral Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-Viral Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anti-Viral Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-Viral Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-Viral Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche Anti-Viral Drugs Major Business
Table 9. F. Hoffmann-La Roche Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 10. F. Hoffmann-La Roche SWOT Analysis
Table 11. F. Hoffmann-La Roche Anti-Viral Drugs Product and Services
Table 12. F. Hoffmann-La Roche Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Cipla Basic Information, Manufacturing Base and Competitors
Table 14. Cipla Anti-Viral Drugs Major Business
Table 15. Cipla Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Cipla SWOT Analysis
Table 17. Cipla Anti-Viral Drugs Product and Services
Table 18. Cipla Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AbbVie Basic Information, Manufacturing Base and Competitors
Table 20. AbbVie Anti-Viral Drugs Major Business
Table 21. AbbVie Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 22. AbbVie SWOT Analysis
Table 23. AbbVie Anti-Viral Drugs Product and Services
Table 24. AbbVie Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Anti-Viral Drugs Major Business
Table 27. GlaxoSmithKline Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 28. GlaxoSmithKline SWOT Analysis
Table 29. GlaxoSmithKline Anti-Viral Drugs Product and Services
Table 30. GlaxoSmithKline Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Aurobindo Pharma Anti-Viral Drugs Major Business
Table 33. Aurobindo Pharma Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Aurobindo Pharma SWOT Analysis
Table 35. Aurobindo Pharma Anti-Viral Drugs Product and Services
Table 36. Aurobindo Pharma Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bristol-Myers-Squibb Basic Information, Manufacturing Base and Competitors
Table 38. Bristol-Myers-Squibb Anti-Viral Drugs Major Business
Table 39. Bristol-Myers-Squibb Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Bristol-Myers-Squibb SWOT Analysis
Table 41. Bristol-Myers-Squibb Anti-Viral Drugs Product and Services
Table 42. Bristol-Myers-Squibb Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co Anti-Viral Drugs Major Business
Table 45. Merck & Co Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Merck & Co SWOT Analysis
Table 47. Merck & Co Anti-Viral Drugs Product and Services
Table 48. Merck & Co Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 50. Johnson & Johnson Anti-Viral Drugs Major Business
Table 51. Johnson & Johnson Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Johnson & Johnson SWOT Analysis
Table 53. Johnson & Johnson Anti-Viral Drugs Product and Services
Table 54. Johnson & Johnson Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Dr Reddy’s Basic Information, Manufacturing Base and Competitors
Table 56. Dr Reddy’s Anti-Viral Drugs Major Business
Table 57. Dr Reddy’s Anti-Viral Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Dr Reddy’s SWOT Analysis
Table 59. Dr Reddy’s Anti-Viral Drugs Product and Services
Table 60. Dr Reddy’s Anti-Viral Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Anti-Viral Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Anti-Viral Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Anti-Viral Drugs Sales by Regions (2015-2020) (K Units)
Table 64. Global Anti-Viral Drugs Sales Market Share by Regions (2015-2020)
Table 65. Global Anti-Viral Drugs Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Anti-Viral Drugs Sales by Countries (2015-2020) (K Units)
Table 67. North America Anti-Viral Drugs Sales Market Share by Countries (2015-2020)
Table 68. North America Anti-Viral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Anti-Viral Drugs Revenue Market Share by Countries (2015-2020)
Table 70. Europe Anti-Viral Drugs Sales by Countries (2015-2020) (K Units)
Table 71. Europe Anti-Viral Drugs Sales Market Share by Countries (2015-2020)
Table 72. Europe Anti-Viral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Anti-Viral Drugs Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Anti-Viral Drugs Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Anti-Viral Drugs Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Anti-Viral Drugs Sales by Countries (2015-2020) (K Units)
Table 77. South America Anti-Viral Drugs Sales Market Share by Countries (2015-2020)
Table 78. South America Anti-Viral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Anti-Viral Drugs Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Anti-Viral Drugs Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Anti-Viral Drugs Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Anti-Viral Drugs Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Anti-Viral Drugs Revenue Market Share by Countries (2015-2020)
Table 84. Global Anti-Viral Drugs Sales by Type (2015-2020) (K Units)
Table 85. Global Anti-Viral Drugs Sales Share by Type (2015-2020)
Table 86. Global Anti-Viral Drugs Revenue by Type (2015-2020) (USD Million)
Table 87. Global Anti-Viral Drugs Revenue Share by Type (2015-2020)
Table 88. Global Anti-Viral Drugs Sales by Application (2015-2020) (K Units)
Table 89. Global Anti-Viral Drugs Sales Share by Application (2015-2020)
Table 90. Global Anti-Viral Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Anti-Viral Drugs Market Share Forecast by Regions (2021-2025)
Table 92. Global Anti-Viral Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Anti-Viral Drugs Market Share Forecast by Type (2021-2025)
Table 94. Global Anti-Viral Drugs Sales Forecast by Application (2021-2025)
Table 95. Global Anti-Viral Drugs Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-Viral Drugs Picture
Figure 2. Global Sales Market Share of Anti-Viral Drugs by Type in 2019
Figure 3. Nucleotide Polymerase Inhibitor Picture
Figure 4. Reverse Transcriptase Inhibitor Picture
Figure 5. Protease Inhibitor Picture
Figure 6. Anti-Viral Drugs Sales Market Share by Application in 2018
Figure 7. HIV Picture
Figure 8. Hepatitis Picture
Figure 9. HSV Picture
Figure 10. Influenza Picture
Figure 11. Global Anti-Viral Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Anti-Viral Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Anti-Viral Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Anti-Viral Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Anti-Viral Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Anti-Viral Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Anti-Viral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Anti-Viral Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Anti-Viral Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Anti-Viral Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Anti-Viral Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Anti-Viral Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Anti-Viral Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Anti-Viral Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Anti-Viral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Anti-Viral Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Anti-Viral Drugs Sales Market Share by Countries in 2018
Figure 48. North America Anti-Viral Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Anti-Viral Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Anti-Viral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Anti-Viral Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Anti-Viral Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Anti-Viral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Anti-Viral Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Anti-Viral Drugs Revenue Market Share by Regions 2019
Figure 64. China Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Anti-Viral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Anti-Viral Drugs Sales Market Share by Countries in 2019
Figure 71. South America Anti-Viral Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Anti-Viral Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Anti-Viral Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Anti-Viral Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Anti-Viral Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Anti-Viral Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Anti-Viral Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Anti-Viral Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Anti-Viral Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Anti-Viral Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Anti-Viral Drugs Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Anti-Viral Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Anti-Viral Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
抗インフルエンザ薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-influenza Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 抗血管内皮増殖因子（抗VEGF）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global marke…
- 抗肝炎ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti Hepatitis Virus Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- アンチエイジング薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Ageing Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.2% in the forecast period of 2020 to 2025 and will expected to reach USD 106360 million by 2025, from USD 80490 million in 2019. The Anti-Ageing Drugs m…
- 抗喘息薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti Asthma Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 24300 million by 2025, from USD 21410 million in 2019. The Anti Asthma Drugs ma…